ReGeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRX) Keeps Pushing Up

[[tagnumber 0]][[tagnumber 1]]After a rather stale performance throughout 2014 the stock of ReGeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRX) has entered this year’s trading quite well. The regular press releases seem to be working well and [[tagnumber 2]]RGRX [[tagnumber 3]]has gained a total of 345% since the beginning of the year.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]We also see an increase in the volumes of traded stock as well as some impressive spikes. Considering the market cap of $58 million that [[tagnumber 2]]RGRX [[tagnumber 3]]has reached by now and looking at what the company had to show in its annual report for 2014 we can very well see that it wouldn’t be that easy for the ticker to continue moving in an upward direction for much longer.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Here are some of the numbers of prime interest contained in the balance sheet of [[tagnumber 2]]RGRX’s [[tagnumber 3]]report for the year ended December 31, 2014.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 19]] [[tagnumber 20]]cash: $844 thousand[[tagnumber 21]] [[tagnumber 20]]current assets: $930 thousand[[tagnumber 21]] [[tagnumber 20]]current liabilities: $409 thousand[[tagnumber 21]] [[tagnumber 20]]total liabilities: $2.66 million[[tagnumber 21]] [[tagnumber 20]]revenue: $0[[tagnumber 21]] [[tagnumber 20]]net loss: $2.75 million[[tagnumber 21]] [[tagnumber 32]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]And although these numbers are not as impressive as those of other biopharmaceutical entities traded in the OTC markets we can’t fail to mention that [[tagnumber 2]]RGRX[[tagnumber 3]] has secured $7.28 million from the government of South Korea and a venture fund for the U.S. development of their RGN–259/GBT–201.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]This has somewhat boosted investor confidence in the company’s stock in recent months and [[tagnumber 2]]RGRX[[tagnumber 3]] finished April with only 5 sessions in the red while constantly issuing press releases. Yesterday’s 11.54% gain pushed the ticker to $0.58, while the 589 traded shares generated $327 thousand in daily dollar volume.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]][[tagnumber 2]]RGRX[[tagnumber 3]] has started today’s session a bit more hesitantly and the company stock is currently 0.54% in the red. In any case, doing your due diligence and weighing out the risks before putting any money on the line is crucial.[[tagnumber 4]]